Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis

Francesco Del Giudice(Sapienza University of Rome), Gian Maria Busetto(Sapienza University of Rome), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Laura S. Mertens(Oncode Institute), Francesco Soria(Medical University of Vienna), Wojciech Krajewski(Wroclaw Medical University), Rocco Simone Flammia(National Cancer Institute), Matteo Ferro(European Institute of Oncology), Ettore De Berardinis(Policlinico Umberto I), Alessandro Sciarra(Policlinico Umberto I), Marco Chirico(University of Foggia), David D‘Andrea(Medical University of Vienna), Vito Mancini(University of Foggia), Vincenzo Asero(Policlinico Umberto I), Luigi Cormio(University of Foggia), Andrea Gallioli(Puigvert Foundation), Tomasz Szydełko(Wroclaw Medical University), Giuseppe Carrieri(University of Foggia), Francesco Cinelli(University of Foggia), Susanna Cattarino(Policlinico Umberto I), Riccardo Autorino(Rush University Medical Center), Nicola d’Altilia(Ospedali Riuniti di Foggia), Martina Maggi(Policlinico Umberto I), Simone Albisinni(University of Rome Tor Vergata), Stefano Salciccia(Policlinico Umberto I), Mario de Angelis(IRCCS Ospedale San Raffaele), Giovanni Cacciamani(University of Southern California), Savio Domenico Pandolfo(University of Salerno), Ekaterina Laukhtina(Sechenov University), Benjamin I. Chung(Stanford Medicine), Marco Moschini(Vita-Salute San Raffaele University), Carlo Maria Scornajenghi(Policlinico Umberto I), Andrea Mari(Azienda Ospedaliero-Universitaria Careggi), Benjamin Pradère, Carlo Bettocchi(University of Foggia)
Cancers
February 10, 2022
Cited by 17


Related Papers